Possible miliary tuberculosis during adalimumab therapy with negative gamma-IFN release assays

Rheumatology (Oxford). 2009 Mar;48(3):319-20. doi: 10.1093/rheumatology/ken469. Epub 2008 Dec 24.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / adverse effects*
  • False Negative Reactions
  • Female
  • Humans
  • Interferon-gamma / biosynthesis*
  • Opportunistic Infections / chemically induced*
  • Spondylitis, Ankylosing / drug therapy
  • Tuberculosis, Miliary / chemically induced*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Interferon-gamma
  • Adalimumab